Cellect Biotechnology Ltd. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced net loss was ILS 816,000 compared to ILS 5.989 million a year ago. Basic loss per share was ILS 0.004 compared to ILS 0.046 a year ago. For the half year, net loss was ILS 5.919 million compared to ILS 9.564 million a year ago. Basic loss per share was ILS 0.029 compared to ILS 0.074 a year ago.